Akışa dön
75/100 Bearish 14.07.2026 · 14:35 Finrend AI ⏱ 1 dk 👁 6 TR

HCA Cuts Profit Forecast Due to Losses Under Obamacare

HCA Healthcare has revised its 2024 profit forecast downward, citing an increase in the number of uninsured patients. The company noted that insurance losses under the Affordable Care Act, commonly known as Obamacare, have raised the proportion of patients without access to healthcare services. This has negatively impacted HCA's revenues and complicated its profitability expectations. According to HCA's new forecast, adjusted earnings per share for 2024 are now expected to be in the range of $19.25 to $20.75, down from the previous estimate of $21.25 to $22.75. The company stated that in addition to the rise in uninsured patient volume, increasing labor costs are also pressuring profit margins. Analysts indicate that these challenges faced by HCA highlight the impact of fluctuations in insurance coverage on companies within the U.S. healthcare sector. Particularly with the completion of Medicaid redetermination processes, many individuals losing insurance coverage are adversely affecting hospitals' revenue structures. HCA's shares declined in pre-market trading following this news. The company aims to offset this negative trend through cost control measures and efforts to enhance operational efficiency. However, if the increase in the uninsured patient rate continues, pressure on profitability is expected to persist. This is not investment advice.

📊 GOOGL — Piyasa Yorumu

■ neutral · 60%

The news headline does not directly impact GOOGL, but a negative development in the health sector could slightly weaken overall market sentiment. Technical indicators are sending mixed signals: the RSI is neutral at 55, the MACD is bullish but the signal line remains negative. The price is above the 20-day SMA but just below the 50-day SMA, creating short-term directional uncertainty. Therefore, no clear direction is expected in the near term.

RSI 14
55.6
MACD
0.09
24h Δ
0.78%

📊 HCA — Piyasa Yorumu

▼ down · 85%

HCA's reduced profit forecast points to losses from Obamacare, its primary revenue source, which will weigh on the stock. Technical indicators also support this bearish outlook: although the RSI at 20.8 is in oversold territory, the MACD is negative and below the signal line, suggesting downside momentum could persist. The price is trading well below the 20- and 50-day moving averages, which may act as resistance. Selling pressure is likely to continue in the near term, with the stock potentially testing lower levels.

RSI 14
20.8
MACD
-12.43
24h Δ
-10.72%
Canlı Grafikler

🔗 İlgili haberler

🧬 Buna benzer

AI tarafından yeniden derlenmiştir. Yatırım tavsiyesi değildir.